Smartkarma AI Primers, Smartkarma

αSK Primers

Smartkarma AI Primers

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

Changchun High & New Tech A / Equity Bottom-Up

<ul>
  <li>Changchun High &amp; New Tech is facing a severe downturn, with a 94% year-over-year decrease in net profit in 2025, driven by pricing pressures and policy adjustments impacting its core pharmaceutical segments.</li>
  <li>The company's primary strength remains its subsidiary, GeneScience Pharmaceutical (GenSci), which is a dominant market leader in China's human growth hormone sector, although this segment is now experiencing significant challenges.</li>
  <li>Future prospects are heavily reliant on the successful execution of its R&amp;D strategy, which includes a pipeline of over 40 clinical candidates and a focus on international expansion to mitigate domestic market risks.</li>
</ul><p><em>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.</em></p>


  Changchun High &amp; New Tech is facing a severe downturn, with a 94% year-over-year decrease in net profit in 2025, driven by pricing pressures and policy adjustments impacting its core pharmaceutical segments.
  The company's primary strength remains its subsidiary, GeneScience Pharmaceutical (GenSci), which is a dominant market leader in China's human growth hormone sector, although this segment is now experiencing significant challenges.
  Future prospects are heavily reliant on the successful execution of its R&amp;D strategy, which includes a pipeline of over 40 clinical candidates and a focus on international expansion to mitigate domestic market risks.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Primer: Changchun High & New Tech A (000661 CH) - Aug 2026

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Changchun High-Tech Industry (CHT HK)

Primer: Changchun High & New Tech A (000661 CH) - Aug 2026

Changchun High & New Tech is facing a severe downturn, with a 94% year-over-year decrease in net profit in 2025, driven by pricing pressures...

αSK Primers

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)